These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3074642)

  • 21. Structural and functional characteristics of currently available PMMA dialyzers.
    Ghezzi PM; Meinero S; Ronco C
    Contrib Nephrol; 1999; 125():25-40. PubMed ID: 9895428
    [No Abstract]   [Full Text] [Related]  

  • 22. Biocompatibility of PMMA membranes in acute and chronic patients with renal failure.
    Manzoni C; Locatelli F
    Contrib Nephrol; 1999; 125():65-75. PubMed ID: 9895431
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical experience with PMMA membrane.
    Albertazzi A; Bonomini M
    Contrib Nephrol; 1999; 125():213-21. PubMed ID: 9895443
    [No Abstract]   [Full Text] [Related]  

  • 24. Biocompatible characteristics of high-performance membranes.
    Uda S; Mizobuchi M; Akizawa T
    Contrib Nephrol; 2011; 173():23-29. PubMed ID: 21865772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term variations of serum beta 2-microglobulin levels in hemodialysed uremics according to permeability and bioincompatibility of dialysis membranes.
    Simon P; Cavarle YY; Ang KS; Cam G; Catheline M
    Blood Purif; 1988; 6(2):111-6. PubMed ID: 3293614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S; Lapcík O; Votruba T
    Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
    Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein adsorption on dialyzer membranes influences their biocompatibility properties.
    Kuwahara T; Markert M; Wauters JP
    Contrib Nephrol; 1989; 74():52-7. PubMed ID: 2562019
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet and leucocyte behaviour during haemodialysis.
    Hoenich NA
    Contrib Nephrol; 1999; 125():120-32. PubMed ID: 9895436
    [No Abstract]   [Full Text] [Related]  

  • 30. Biocompatibility of dialysis membranes: a comparative study.
    Martin-Malo A; Castillo D; Castro M; Pérez R; Rios A; Jaraba M; Aljama P
    Nephrol Dial Transplant; 1991; 6 Suppl 2():55-8. PubMed ID: 1866069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane?
    Floege J; Granolleras C; Koch KM; Shaldon S
    Nephron; 1988; 50(3):177-81. PubMed ID: 3067100
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of an erythropoietic inhibitor from the dialysate collected in the hemodialysis with PMMA membrane (BK-F).
    Yamada S; Kataoka H; Kobayashi H; Ono T; Minakuchi J; Kawano Y
    Contrib Nephrol; 1999; 125():159-72. PubMed ID: 9895438
    [No Abstract]   [Full Text] [Related]  

  • 33. Biocompatibility of haemodialysis membranes.
    Hoenich NA; Levett D; Fawcett S; Woffindin C; Kerr DN
    J Biomed Eng; 1986 Jan; 8(1):3-8. PubMed ID: 3512914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodialysis membrane biocompatibility--does it matter?
    Jacobson SH
    Scand J Urol Nephrol; 1999 Apr; 33(2):83-8. PubMed ID: 10360446
    [No Abstract]   [Full Text] [Related]  

  • 35. Biocompatibility of haemodialysis membranes: it matters in acute renal failure.
    Krediet RT
    Neth J Med; 1995 Nov; 47(5):205-7. PubMed ID: 8544890
    [No Abstract]   [Full Text] [Related]  

  • 36. Biocompatibility study on cuprophane and polysulphone dialysers.
    Taraba I; Polner K; Makó J
    Nephrol Dial Transplant; 1991; 6 Suppl 3():22-5. PubMed ID: 1775261
    [No Abstract]   [Full Text] [Related]  

  • 37. Membrane biocompatibility: clinical significance and therapeutic implications.
    Dumler F; Levin NW
    Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
    [No Abstract]   [Full Text] [Related]  

  • 38. Review: membranes for haemodialysis.
    Kerr PG; Huang L
    Nephrology (Carlton); 2010 Jun; 15(4):381-5. PubMed ID: 20609086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biocompatibility and the clinical choice of dialysis membranes.
    Mujais SK; Ivanovich P; Bereza LA; Vidovich M
    Contrib Nephrol; 1995; 113():101-9. PubMed ID: 7712716
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
    Schaefer RM; Hörl WH; Kokot K; Heidland A
    Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.